Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.

Hannouneh ZA, Issa M, Mizuno H, Murakami N

Open source

DOI
10.1097/tp.0000000000005856
Published
2026 Aug 27
Container
Transplantation
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/tp.0000000000005856,
  title = {Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.},
  author = {Hannouneh ZA and Issa M and Mizuno H and Murakami N},
  year = {2026},
  journal = {Transplantation},
  doi = {10.1097/tp.0000000000005856},
  url = {https://doi.org/10.1097/tp.0000000000005856}
}

RIS

TY  - JOUR
TI  - Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.
AU  - Hannouneh ZA
AU  - Issa M
AU  - Mizuno H
AU  - Murakami N
PY  - 2026
JO  - Transplantation
DO  - 10.1097/tp.0000000000005856
UR  - https://doi.org/10.1097/tp.0000000000005856
ER  - 

APA

ZA, H., M, I., H, M., & N, M. (2026). Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.. Transplantation. https://doi.org/10.1097/tp.0000000000005856

Source records